Esperion Therapeutics Inc.
ESPR:NASDAQ
Esperion is the Lipid Management Company committed to developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated LDL-C.
Streetwise Company Fact Sheet2025/1/14 7:35:21
(ESPR:NASDAQ)
Analyst coverage
| Needham & Co — Serge Belanger |
| JMP Securities — Jason Butler |
| Jefferies & Co. — Dennis Ding |
| J.P. Morgan — Jessica Fye |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
| BTIG Research — Dr. Thomas Shrader |
| Bank of America Securities — Dr. Jason Zemansky |
Streetwise Reports Articles
| 12/03/2024 - View Article |
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
